CURO Group Holdings Corp.: Nasdaq/NYSE listing notice — CURO Group receives NYSE notice for non-compliance with $1.00 minimum share price; has until April 27, 2024 to cure

CURO Group Holdings Corp.

NYSE notified CURO on Oct 27, 2023 that avg closing price over prior 30 trading days was below $1.00 per share.
CURO has six months (until April 27, 2024) to regain compliance by achieving $1.00+ closing and 30-day average.
Stock will trade under symbol CURO with '.BC' indicator until compliance is regained.
If not cured, NYSE will initiate suspension and delisting procedures; business operations unaffected.
No event of default under material debt agreements; company plans to notify NYSE of intent to cure.

item 3.01 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

CURO Group Holdings Corp. received a nyse deficiency notice notice regarding minimum bid price (rules 802.01C).

Exchange: nyse
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 802.01C

Exact text from the filing

October 27, 2023, Curo Group Holdings Corp. (the “Company”) received notice (the “Notice”) from the New York Stock Exchange (the “NYSE”) that it is no longer in compliance with the NYSE continued listing standard set forth in Section 802.01C of the NYSE’s Listed Company Manual due to the fact that the average closing price of the Company’s common stock, par value $0.10 per share (the “Common Stock”), over the prior 30 consecutive trading days was below $1.00 per share. As required by the NYSE, the Company plans to notify the NYSE of its intent to cure the price deficiency and restore its compl

View on SEC.gov

Browse all listing & compliance notices →

Source: SEC EDGAR

accession 0001711291-23-000100

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.